(6) Studies have also linked vitamin D deficiency to Alzheimers, cognitive impairment, and dementia
In addition, vitamin B deficiency can disrupt the methylation of homocysteine, leading to hyperhomocysteinemia
The available evidence consists primarily of animal studies and limited early-phase human trials, with no published phase III clinical trial data demonstrating efficacy in inflammatory bowel disease (IBD).[1][2] The literature describes BPC-157 as a stable gastric pentadecapeptide that was tested in phase II clinical trials for inflammatory bowel disease (referenced as PL 14736), with reports indicating it was "safe" and had "no side effects." However, a 2025 review emphasizes that BPC-157 "has not been approved for use in standard medicine by the FDA and other global regulatory authorities due to the absence of sufficient and comprehensive clinical studies confirming its health benefits in humans."[1][3][2] The preclinical evidence is extensive but limited to animal models
is an enterprise integrating research and development, production and sales of beauty equipment
Even some clinics statements, such as BPC-157 promoting the healing of various tissues in humans [10], are not yet backed up by robust clinical trials
Tregs play a significant role in controlling the immune response